Further studies found that KXS can reduce glucocorticoid secretion by regulating the levels of serum cytokines (such as COX, IL-2, and TNF-α) while inhibiting HPA axis hyperactivity and inhibiting apoptosis and thus treating depression. The gene discussed is TNF; the disease is major depressive disorder.